Simultaneous, separate or Sequential a PPAR gamma agonist with a selected Group of glitazones isolated Nrf2 Activator selected from a specific group or a composition containing, for the treatment of an inflammatory autoimmune disorder and / or Pharmaceutical composition. That includes the PPAR gamma agonist and Nrf2 Activator； and kit that includes it.
The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.USO DE UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE PIOGLITAZONA O ROSIGLITAZONA Y UN ACTIVADOR DE NRF2 AISLADO SELECCIONADO DE ÉSTERES DE ÁCIDO FUMÁRICO PARA PREPARAR UN MEDICAMENTO ÚTIL EN EL TRATAMIENTO DE ESCLEROSIS MÚLTIPLE Y SÍNDROME CLÍNICAMENTE AISLADO； COMBINACIÓN FARMACÉUTICA； FORMA DE DOSIS.
